186 related articles for article (PubMed ID: 20811368)
1. Potential remains for PPAR-targeted drugs.
Jones D
Nat Rev Drug Discov; 2010 Sep; 9(9):668-9. PubMed ID: 20811368
[No Abstract] [Full Text] [Related]
2. Mechanism of antiplatelet action of hypolipidemic, antidiabetic and antihypertensive drugs by PPAR activation: PPAR agonists: new antiplatelet agents.
Fuentes E; Palomo I
Vascul Pharmacol; 2014 Sep; 62(3):162-6. PubMed ID: 24874279
[TBL] [Abstract][Full Text] [Related]
3. [Non-agonist inhibitors of Cdk5-dependent phosphorylation of PPAR as insulin sensitizers in the future?].
Merk D; Schubert-Zsilavecz M
Pharm Unserer Zeit; 2012 May; 41(3):182-3. PubMed ID: 22844662
[No Abstract] [Full Text] [Related]
4. American Diabetes Association - 65th Scientific Sessions. PPAR agents.
Erlich R
IDrugs; 2005 Aug; 8(8):608-10. PubMed ID: 16044361
[No Abstract] [Full Text] [Related]
5. Peroxisome proliferator activated receptor ligands for the treatment of insulin resistance.
Patsouris D; Müller M; Kersten S
Curr Opin Investig Drugs; 2004 Oct; 5(10):1045-50. PubMed ID: 15535425
[TBL] [Abstract][Full Text] [Related]
6. Virtual screening for PPAR modulators using a probabilistic neural network.
Derksen S; Rau O; Schneider P; Schubert-Zsilavecz M; Schneider G
ChemMedChem; 2006 Dec; 1(12):1346-50. PubMed ID: 17066499
[No Abstract] [Full Text] [Related]
7. Deal watch: Metabolex and Sanofi-Aventis partner on GPCR agonists for type 2 diabetes.
Nat Rev Drug Discov; 2010 Sep; 9(9):670. PubMed ID: 20811370
[No Abstract] [Full Text] [Related]
8. The next generation of PPAR drugs: do we have the tools to find them?
Shearer BG; Billin AN
Biochim Biophys Acta; 2007 Aug; 1771(8):1082-93. PubMed ID: 17602866
[TBL] [Abstract][Full Text] [Related]
9. Fine tuning of PPAR ligands for type 2 diabetes and metabolic syndrome.
Ramachandran U; Kumar R; Mittal A
Mini Rev Med Chem; 2006 May; 6(5):563-73. PubMed ID: 16719831
[TBL] [Abstract][Full Text] [Related]
10. Peroxisome proliferator-activated receptors and angiogenesis.
Biscetti F; Straface G; Pitocco D; Zaccardi F; Ghirlanda G; Flex A
Nutr Metab Cardiovasc Dis; 2009 Dec; 19(11):751-9. PubMed ID: 19628379
[TBL] [Abstract][Full Text] [Related]
11. Thiazolidinediones as antidiabetic agents: A critical review.
Nanjan MJ; Mohammed M; Prashantha Kumar BR; Chandrasekar MJN
Bioorg Chem; 2018 Apr; 77():548-567. PubMed ID: 29475164
[TBL] [Abstract][Full Text] [Related]
12. Effects of thiazolidinediones beyond glycaemic control.
Kalaitzidis RG; Sarafidis PA; Bakris GL
Curr Pharm Des; 2009; 15(5):529-36. PubMed ID: 19199979
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of new 8(S)-HETE analogs and their biological evaluation as activators of the PPAR nuclear receptors.
Liutkus M; Caijo F; Girard AL; Ayral E; Audinot V; Boutin JA; Renard P; Caignard DH; Dacquet C; Ktorza A; Mosset P; Grée R
J Enzyme Inhib Med Chem; 2010 Oct; 25(5):653-72. PubMed ID: 20518620
[TBL] [Abstract][Full Text] [Related]
14. [Dipeptidylpeptidase IV inhibitors and dual action PPAR-agonists].
Heinzl S
Med Monatsschr Pharm; 2006 Mar; 29(3):93-6. PubMed ID: 16550882
[No Abstract] [Full Text] [Related]
15. Chiglitazar: First Approval.
Deeks ED
Drugs; 2022 Jan; 82(1):87-92. PubMed ID: 34846697
[TBL] [Abstract][Full Text] [Related]
16. PPAR dual agonists: are they opening Pandora's Box?
Balakumar P; Rose M; Ganti SS; Krishan P; Singh M
Pharmacol Res; 2007 Aug; 56(2):91-8. PubMed ID: 17428674
[TBL] [Abstract][Full Text] [Related]
17. Advances in insulin sensitizers.
Lohray BB; Bhushan V
Curr Med Chem; 2004 Sep; 11(18):2467-503. PubMed ID: 15379708
[TBL] [Abstract][Full Text] [Related]
18. Rational drug design and PPAR agonists.
Perfetti R; D'Amico E
Curr Diab Rep; 2005 Oct; 5(5):340-5. PubMed ID: 16188168
[TBL] [Abstract][Full Text] [Related]
19. MK-767. Kyorin/Banyu/Merck.
Calkin AC; Thomas MC; Cooper ME
Curr Opin Investig Drugs; 2003 Apr; 4(4):444-8. PubMed ID: 12808885
[TBL] [Abstract][Full Text] [Related]
20. Rational targeting of peroxisome proliferating activated receptor subtypes.
Nevin DK; Lloyd DG; Fayne D
Curr Med Chem; 2011; 18(36):5598-623. PubMed ID: 22172067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
